Home > Boards > US OTC > Biotechs > Health Discovery Corporation (HDVY)

Alan, I believe you raise some excellent points.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
MBMoney Member Profile
 
Followed By 1
Posts 107
Boards Moderated 0
Alias Born 10/27/16
160x600 placeholder
MBMoney   Thursday, 07/30/20 11:42:42 AM
Re: alan81 post# 14976
Post # of 15076 
Alan, I believe you raise some excellent points. Most of us are certainly hopeful that the Intel suit is actually an open and shut case, but something may almost appear 'too good' about this opportunity, and HDC's strategy thus far concerns me.

The use of SVM-RFE appears to be widespread, and its use spans numerous companies, large and small. I took a look at Amazon's use of machine learning, and the company has apparently made it very practical (if not easy) for even the layperson to take advantage of it. In particular, I found information about Amazon's solutions for fraud detection, which companies can take advantage of, and it's straightforward. With this in mind, I'm troubled by the fact that over a year has gone by since the USPTO ruling, and HDC has not monetized a thing. Surely, given the ever-increasing focus on AI and the need to better analyze vast amounts of data, I can't understand why HDC hasn't established a consulting business through which it can provide enhanced support to companies to improve data analysis via use of the SVM-RFE technology. I can't imagine that this wouldn't drive revenues, and we've already lost a year holding exclusive rights to the patent.

Since they haven't monetized anything, let's hope that the team hasn't put all its eggs in the infringement basket because, if they either don't win, or this drags out, HDC leadership may have done us a very grave disservice by 'banking on' a big payout.

I remain hopeful about the infringement case, but I also want desperately to see some formal movement on development of products and services utilizing our IP. By the way, a number of our patents are expiring this year, and never translated into money for the company.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist